arrow
L

Laura Mondragón

INSERM
H指数:34
被引数:8,808

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma
2024-06-190
OAAI
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
2021-05-1122
OAAI
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (July, 10.1038/s41467-020-17644-0, 2020)

激素受体阳性乳腺癌的免疫预防和免疫治疗控制 (7月,10.1038/s41467-020-17644-0,2020)

2020-09-170
OAAI
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
2020-08-01226
OAAI
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

激素受体阳性乳腺癌的免疫预防和免疫治疗控制

2020-07-3084
OAAI
Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice
2019-06-0122
OAAI
AIF-regulated oxidative phosphorylation supports lung cancer development
2019-05-2771
OAAI
Tumor lysis with LTX-401 creates anticancer immunity
2019-04-1331
OAAI
Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate
2019-04-0132
OAAI
Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance
2018-04-01104
OAAI
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

肠道菌群影响PD-1-based免疫治疗上皮性肿瘤的疗效

Science
IF45.8
2017-01-010
PREAI